Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Tibet Rhodiola Pharmaceutical Holding Co
Other Operating Expenses
Tibet Rhodiola Pharmaceutical Holding Co
Other Operating Expenses Peer Comparison
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
|
Other Operating Expenses
¥186.4m
|
CAGR 3-Years
55%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Other Operating Expenses
¥694.7m
|
CAGR 3-Years
6%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Other Operating Expenses
¥678.6m
|
CAGR 3-Years
10%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Other Operating Expenses
¥230.1m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Other Operating Expenses
¥72.1m
|
CAGR 3-Years
69%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
Huadong Medicine Co Ltd
SZSE:000963
|
Other Operating Expenses
¥47.3m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
13%
|
See Also
What is Tibet Rhodiola Pharmaceutical Holding Co's Other Operating Expenses?
Other Operating Expenses
186.4m
CNY
Based on the financial report for Dec 31, 2023, Tibet Rhodiola Pharmaceutical Holding Co's Other Operating Expenses amounts to 186.4m CNY.
What is Tibet Rhodiola Pharmaceutical Holding Co's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
26%
Over the last year, the Other Operating Expenses growth was 3 022%. The average annual Other Operating Expenses growth rates for Tibet Rhodiola Pharmaceutical Holding Co have been 55% over the past three years , 26% over the past five years .